Search for:
CytomX
Search for:
About
Overview
Vision & Mission
Our Values
Executive Team
Board of Directors
Scientific Advisory Board
Contact Us
Probody Therapeutics
Our Probody Approach
How Probody Therapeutics Work
A Versatile Platform
Scientific Publications & Presentations
Pipeline
Advancing our Pipeline
Lead Candidates
Clinical Trials
Access for HCPs/Patients
Partners
Opportunities
Current Partners
Investors & News
Corporate Profile
Press Releases
Events & Presentations
Scientific Publications
Corporate Governance
Stock Information
Financial & Filings
Analyst Coverage
Investor Resources
Culture & Careers
Overview
Mission-Driven Culture
Current Openings
Total Rewards Program
Corporate Amenities
Home
Terms of use
Privacy notices
Disclaimer for Twitter
Menu
Transforming lives with safer, more effective therapies.
Designing In and Around Tolerability Considerations for Immunotherapy Combinations
Clinical Pharmacology & Therapeutics
; Stroh, M.; April 2018.